Martin Gawlitzek
Advertisement
Martin Gawlitzek is a senior scientist at late stage cell culture, US Biologics Pharma Technical Development, Genentech, Inc.
Articles by Martin Gawlitzek
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
Amgen Real-World Study Links Evolocumab to Lower Heart Attack Risk Than Ezetimibe
2
FDA Approves Rybrevant Faspro for Advanced Head and Neck Cancer
3
T-Therapeutics Raises $133 Million to Take TCR Bispecifics Into the Clinic
4
Alethio Raises $90 Million to Advance First-in-Class G6B Antibody for Essential Thrombocythemia
5